Trial Profile
A Phase I Clinical Trial to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and Rosuvastatin in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Jan 2020
Price :
$35
*
At a glance
- Drugs Fimasartan/rosuvastatin (Primary) ; Fimasartan; Rosuvastatin
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Boryung Pharmaceutical
- 14 Oct 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
- 08 Aug 2014 New trial record